Blood transcript levels of BCL2, BAX and TP53 as well as the BCL2/BAX ratio were correlated with MJD subjects’ demographic, genetic and clinical features (Supplementary Table S5). This evidence concerns the gene TP53 and Machado-Joseph disease.